...
首页> 外文期刊>Pathology International >Dysplastic follicular dendritic cells in hyaline-vascular Castleman disease: a rare occurrence creating diagnostic difficulty
【24h】

Dysplastic follicular dendritic cells in hyaline-vascular Castleman disease: a rare occurrence creating diagnostic difficulty

机译:透明血管Castleman病中发育异常的滤泡性树突状细胞:一种罕见的情况,诊断困难

获取原文
获取原文并翻译 | 示例
           

摘要

Follicular dendritic cell (FDC) proliferations and dysplastic FDCs can be seen in Hyaline-vascular Castleman disease (HVCD). The association between HVCD and FDC sarcoma is well-documented; dysplastic FDCs may be precursors to FDC sarcoma. Herein, we describe a case of HVCD with strikingly large and dysplastic FDCs, which raised the differential of Hodgkin lymphoma and other neoplasms. Scattered dysplastic FDCs were predominantly in germinal centers and mantle zones, and rarely in interfollicular areas. Although occasional germinal centers contained increased FDCs, no mass forming proliferations were present to suggest FDC sarcoma. Immunostaining demonstrated that the atypical FDCs expressed CD21, clusterin and CXCL13, but not CD23, S100, pankeratin or CD30; they aberrantly expressed epidermal growth factor receptor (EGFR). The present case demonstrates that dysplastic FDCs may be present as isolated cells that require immunophenotyping to distinguish them from malignant entities with similar morphologic features. A variety of FDC markers is required to confirm their origin as the expression of any single marker is not assured, as occurred in this case. Pathologists need be aware of FDC proliferations in HVCD because of their association with FDC sarcoma. Aberrant EGFR expression by dysplastic FDCs may indicate that they are pre-neoplastic and necessitate long-term patient follow-up.
机译:Hyaline-血管Castleman病(HVCD)中可见滤泡性树突状细胞(FDC)增殖和发育不良FDCs。 HVCD与FDC肉瘤之间的关联有据可查。发育不良的FDC可能是FDC肉瘤的前体。在这里,我们描述了一个HVCD病例,其FDC异常大而异常增生,从而引起了霍奇金淋巴瘤和其他肿瘤的鉴别。散在的异常增生的FDC主要在生发中心和地幔区,而在小孔间区域则很少。尽管偶尔的生发中心包含增加的FDC,但并未出现大量形成增生的现象提示FDC肉瘤。免疫染色显示非典型FDC表达CD21,簇蛋白和CXCL13,但不表达CD23,S1​​00,pankeratin或CD30。他们异常表达表皮生长因子受体(EGFR)。本病例证明发育异常的FDCs可以作为分离的细胞存在,需要进行免疫表型鉴定以将其与具有相似形态特征的恶性实体区分开。需要多种FDC标记来确认其起源,因为这种情况下无法确保任何单个标记的表达。病理学家需要了解HVCD中FDC的增殖,因为它们与FDC肉瘤相关。异常增生的FDC异常表达EGFR可能表明它们是肿瘤前期的,需要长期的患者随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号